Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 129-136

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models

By            

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 425-432

Spandidos Publications

Access to resources Recommend Favorite

The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors

By Lu Jianjun   Jackson John   Gleave Martin   Burt Helen  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 997-1005

Springer Publishing Company

Access to resources Recommend Favorite

The bicalutamide Early Prostate Cancer Program - Demography

By See W.A.   McLeod D.   Iversen P.   Wirth M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 2, 2001-03 ,pp. : 43-47

Elsevier

Access to resources Recommend Favorite

Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 8, 2016-07 ,pp. : 1038-1042

Bentham Science Publishers

Access to resources Recommend Favorite